Argenx Se (ARGX) Interest Coverage Ratio (2019 - 2022)
Argenx Se (ARGX) posted Interest Coverage Ratio of 389.61 for Q2 2022, down 266.71% on a QoQ basis from 233.71 in Q1 2022, and down 100.0% year-over-year from 17015707589.6 in Q2 2021.
Argenx Se (ARGX) Interest Coverage Ratio (2019 - 2022) Analysis & Trends
Argenx Se's Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 389.61 for Q2 2022.
- Quarterly Interest Coverage Ratio fell 100.0% year-over-year to 389.61 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was 1342.31 (up 100.0% YoY) and the FY2025 annual result came in at 258.16, up 3037.58% from the prior year.
- Interest Coverage Ratio was 389.61 for Q2 2022 at Argenx Se, down from 233.71 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 17015707458.94 in Q2 2021 and bottomed at 4153.24 in Q3 2019.
- A 3-year average of 4665905255.11 and a median of 77.95 in 2022 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 100.0% in 2022, while the deepest fall reached 100.0% in 2022.
- Argenx Se's Interest Coverage Ratio stood at 1348.85 in 2019, then jumped by 1261495917.43% to 17015707458.94 in 2021, then slumped by 100.0% to 389.61 in 2022.
- Business Quant data shows ARGX's Interest Coverage Ratio at 389.61 in Q2 2022, 233.71 in Q1 2022, and 17015707458.94 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -389.61 |
| Mar 31, 2022 | 233.71 |
| Jun 30, 2021 | 17.02 Bn |
| Mar 31, 2021 | 10.98 Bn |
| Dec 31, 2019 | -1,348.85 |
| Sep 30, 2019 | -4,153.24 |